Genomic Context

The genome browser snapshot is fully interactive. Mouse over track elements for more information. Click and drag to move tracks. Click and drag on top positional guide to zoom to a sub-region.

To add tracks, use the provided link to switch to the full genome browser view.

Gene-based Trait Associations

Back to Top

ADSP WES: Alzheimer's Disease ADSP

Results from gene-level rare and functional variant aggregation tests for association to AD supported by significane of p < 0.5 / #genes.

Individual score test statistics for rare, predicted functional, and loss of function variants colocated with the gene were aggregated to compute gene level p-values.

See NIAGADS Accession NG00065 for more information.

Back to Top
Accession Population N SNPs p-value Sign. Level rho CMAF CMAC Covariates Variant Filter Caveats
NG00065 European 19 0.352 N/A 1 4.8e-03 100.2 PCs, sequencing center, sex, and age at AD onset or last-known dementia-free age (for controls) VEP MOD-HIGH N/A
NG00065 Caribbean Hispanic 2 0.354 N/A 1 0.030 24.0 PCs, sequencing center, sex, age at AD onset or last-known dementia-free age (for controls), and APOE E2 and E4 genotypes VEP MOD-HIGH N/A
NG00065 Caribbean Hispanic 2 0.376 N/A 1 0.030 24.0 PCs, sequencing center, sex, and age at AD onset or last-known dementia-free age (for controls) VEP MOD-HIGH N/A
NG00065 European 1 0.400 N/A 0 4.8e-05 1.0 PCs and sequencing center LOF
NG00065 European 1 0.400 N/A 0 4.8e-05 1.0 PCs and sequencing center VEP HIGH
NG00065 Caribbean Hispanic 2 0.428 N/A 1 0.030 24.0 PCs and sequencing center VEP MOD-HIGH N/A
NG00065 Meta 20 0.532 N/A 0 5.7e-03 124.2 PCs and sequencing center VEP MOD-HIGH N/A
NG00065 European 19 0.562 N/A 0 4.8e-03 100.2 PCs and sequencing center VEP MOD-HIGH N/A
NG00065 Meta 20 0.630 N/A 1 5.7e-03 124.2 PCs, sequencing center, sex, and age at AD onset or last-known dementia-free age (for controls) VEP MOD-HIGH N/A
NG00065 European 19 0.634 N/A 1 4.8e-03 100.2 PCs, sequencing center, sex, age at AD onset or last-known dementia-free age (for controls), and APOE E2 and E4 genotypes VEP MOD-HIGH N/A
NG00065 Meta 20 0.752 N/A 0 5.7e-03 124.2 PCs, sequencing center, sex, age at AD onset or last-known dementia-free age (for controls), and APOE E2 and E4 genotypes VEP MOD-HIGH N/A
NG00065 European 1 0.812 N/A 0 4.8e-05 1.0 PCs, sequencing center, sex, age at AD onset or last-known dementia-free age (for controls), and APOE E2 and E4 genotypes VEP HIGH
NG00065 European 1 0.812 N/A 0 4.8e-05 1.0 PCs, sequencing center, sex, age at AD onset or last-known dementia-free age (for controls), and APOE E2 and E4 genotypes LOF
NG00065 European 1 0.841 N/A 0 4.8e-05 1.0 PCs, sequencing center, sex, and age at AD onset or last-known dementia-free age (for controls) LOF
NG00065 European 1 0.841 N/A 0 4.8e-05 1.0 PCs, sequencing center, sex, and age at AD onset or last-known dementia-free age (for controls) VEP HIGH

Genetic Variation and Variant-based Trait Associations (GWAS)

Variants contained within the HLA-DRA gene.

Back to Top

The HLA-DRA gene contains 435 variants records (corresponding to 412 unique genomic positions).

The following variants, contained within ±100kb of HLA-DRA, have been found to be associated with Alzheimer's disease in a GWAS study:

NIAGADS GWAS: Alzheimer's Disease

Variants contained within ±100kb of HLA-DRA that have genome-wide significance in a NIAGADS Alzheimer's Disease GWAS summary statistics dataset; supported by a p-value < 5 x 10-8. For exome array studies, a cutoff of p-value < 1 x 10-3 was used.

Click on accession numbers to view a detailed report about the dataset or to request access to the data.

Back to Top

Login in to select variants and add them to your basket.

Relative Position Variant ADSP? Allele p-Value Track Accession
in gene N/A 8.2e-20 ADSP Single-Variant Risk Association: Caribbean Hispanic (Model 1) NG00065
in gene N/A 8.2e-20 ADSP Single-Variant Risk Association: European (Model 1) NG00065
in gene N/A 8.2e-20 ADSP Single-Variant Risk Association: meta analysis (Model 1) NG00065
in gene N/A 4.4e-17 ADSP Single-Variant Risk Association: meta analysis (Model 2) NG00065
in gene N/A 4.4e-17 ADSP Single-Variant Risk Association: European (Model 2) NG00065
in gene N/A 4.4e-17 ADSP Single-Variant Risk Association: Caribbean Hispanic (Model 2) NG00065
upstream N/A 1.4e-10 ADSP Single-Variant Risk Association: Caribbean Hispanic (Model 1) NG00065
upstream N/A 1.4e-10 ADSP Single-Variant Risk Association: European (Model 1) NG00065
upstream N/A 1.4e-10 ADSP Single-Variant Risk Association: meta analysis (Model 1) NG00065
downstream C 3.3e-10 IGAP 2013: Stages 1 and 2 NG00036
upstream N/A 1.0e-9 ADSP Single-Variant Risk Association: Caribbean Hispanic (Model 2) NG00065
upstream N/A 1.0e-9 ADSP Single-Variant Risk Association: meta analysis (Model 2) NG00065
upstream N/A 1.0e-9 ADSP Single-Variant Risk Association: European (Model 2) NG00065
downstream C 3.9e-9 IGAP 2013: Stages 1 and 2 NG00036
downstream C 3.9e-9 IGAP 2013: Stages 1 and 2 NG00036
upstream C 9.9e-9 IGAP 2013: Stages 1 and 2 NG00036
downstream N/A C 1.5e-8 IGAP 2013: Stage 1 NG00036
upstream C 1.6e-8 IGAP 2013: Stages 1 and 2 NG00036
upstream A 1.6e-8 IGAP 2013: Stages 1 and 2 NG00036
downstream N/A C 3.2e-8 IGAP 2013: Stage 1 NG00036
downstream N/A T 3.2e-8 IGAP 2013: Stage 1 NG00036

NHGRI GWAS: Alzheimer's Disease

Variants contained within ±100kb of HLA-DRA that are associated with Alzheimer's disease in the NHGRI GWAS Catalog.

The following variants, contained within ±100kb of HLA-DRA, have been associated with AD-relevant neuropathologies in a GWAS study:

NIAGADS GWAS: AD biomarkers and related neuropathologies

Variants contained within ±100kb of HLA-DRA that have genome-wide significance in a NIAGADS GWAS summary statistics dataset; supported by a p-value < 5 x 10-8. For exome array studies, a cutoff of p-value < 1 x 10-3 was used.

Click on accession numbers to view a detailed report about the dataset or to request access to the data.

NHGRI GWAS: Other Traits (incl. related neuropathologies and AD biomarkers)

Variants contained within ±100kb of HLA-DRA that are associated with a trait in the NHGRI GWAS Catalog.

Functional Genomics

Back to Top

Explore all functional genomics annotations within the region of the HLA-DRA gene (chr6:32407619-32412823)

Transcription Factor Binding Site Overlap in Gene Promoter Region (ENCODE ChIP-SEQ)

ChIP-Seq sites for transcription factor binding (from selected brain-relevant ENCODE tracks) within the promoter region of this gene. See methods for more information.

Functional Annotation

Gene Ontology

Functional annotations were obtained from UniProt-GOA gene association files.

Click on a term accession number to view term details at the Gene Ontology Consortium.

KEGG Pathways

Click on a pathway accession number to view term details at KEGG.

Click on the number in the Find Similar column to get a list of genes annotated by the associated pathway.

Back to Top
Pathway KEGG Accession Graph
Allograft rejection hsa05330
Antigen processing and presentation hsa04612
Asthma hsa05310
Autoimmune thyroid disease hsa05320
Cell adhesion molecules (CAMs) hsa04514
Epstein-Barr virus infection hsa05169
Graft-versus-host disease hsa05332
Hematopoietic cell lineage hsa04640
Herpes simplex infection hsa05168
HTLV-I infection hsa05166
Inflammatory bowel disease (IBD) hsa05321
Influenza A hsa05164
Intestinal immune network for IgA production hsa04672
Leishmaniasis hsa05140
Phagosome hsa04145
Rheumatoid arthritis hsa05323
Staphylococcus aureus infection hsa05150
Systemic lupus erythematosus hsa05322
Th17 cell differentiation hsa04659
Th1 and Th2 cell differentiation hsa04658
Toxoplasmosis hsa05145
Tuberculosis hsa05152
Type I diabetes mellitus hsa04940
Viral myocarditis hsa05416